## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |hown
in the table belo|w:|| |---|---|---| ||Role|Dates in post during| |||2020/2021| |Gillian
Norton|Chairman|31/3/20 to 31/3/21| |Patricia Baskerville|Non-Executive|31/3/20 to 31/12/20| |Elizabeth
Bishop|Non-Executive|31/3/20 to 31/3/21| |Professor Derek Macallan|Non-Executive
Director|31/3/20 to 31/3/21| |Phillip Wilbraham|Non-Executive
Director|3/0/20 to 31/3/21| |Richard
Noble|Non-Executive
Director|31/3/20 to 31/3/21| |Aruna
Mehta|Non-Executive
Director|31/3/20 to 31/3/21| |Martin Kirke|Ass Non Executive Director|31/3/20 to 31/3/21| |Chris Elliot|Ass Non Executive Director|31/3/20 to 31/3/21| |Daniel Elkeles|Chief Executive|31/3/20 to 31/3/21| |Rakesh Patel|Chief Finance Officer|31/3/20 to 31/3/21| |DrJames Marsh|Deputy Chief Executive and Joint Medical Director|31/3/20 to 31/3/21| |Dr Ruth Charlton|Deputy Chief Executive and Joint Medical Director|31/3/20 to 31/3/21| |Sue Jones|Joint Chief Operating
Officer|31/3/20 to 31/3/21| |Phillips Jones|Joint Chief Operating
Officer|31/3/20 to 31/3/21| |Arlene Wellman|Chief Nurse|31/3/20 to 31/3/21| |Debbie Eyitayo|Director ofPeople|31/3/20 to 31/3/21| |Peter Davies|Director ofStrategy|31/3/20 to 31/3/21| |Trevor Fitzgerald|Director of Estates Facilities and Capital Projects|31/3/20 to 31/3/21| |Thirza Sawtell|Director of Integrated
Care|31/3/20 to 31/3/21| |Lisa Thomson|Director ofCommunications|1/4/20 to 31/7/20| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||||2020t2021||2019/2020|2019/2020|| |---|---|---|---|---|---|---|---|---| ||||Unrestricted|Restricted|Total|Unrestrlcts|Restricts|Total| |||||||d|d|| ||||Funds|Furtds|Funds|Funds|Funds|Funds| ||||fr000|6'000|fr000|M000|M000|K'000| |Income from:||||||||| |Donations||Note 3|226|176|402|190|186|370| |Other trading
activities||Note 3|11|0|11|28|0|28| |Legacies||Note 3|354|0|354|143|0|143| |Investment
Income||Note 5|27|0|27|42|0|42| |Total Income|||618|176|794|403|188|591| |Expenditure
on:||||||||| |Raising funds||||||||| |Investment
management
Fundraising
Costs|costs|Note 6|(26)
(96)|(3)
0|(29)
(98)|(0)
(73)|0
0|(9)
(73)| |Expenditure
on charilabie||||||||| |activities||||||||| |Patients welfare and amenities
Staffwelfare and amenities
Research Expenditure
DonatIons ofequipment
and||Note 7
Note 7
Note 7
Note 7|n)
(83)
n)
(162)|0
(150)
0
0|(1)
(213)
(1)
(182)|(13)
(66)
0
(675)|0
0
0
0|(13)
(88)
0
(675)| |sslvlces to the Trust||||||||| |Volunteers
and miscellaneous||Note 7|0|0|0|(0)|0|(9)| |expenses||||||||| |Total Expenditure|||(369)|(153)|(522)|(867)|0|(867)| |Realised and Unrealised|Gains||526|36|582|(120)|0|(128)| |(losses) on Investment|assets|||||||| |Net Movement
In Funds|||775|59|034|590|108|402| |Reconciliation
offunds:||||||||| |Fund balances
brought|forward||2,397|185|2,585|||| |as at 1 April 2020||||||||| |Fund balances
brought|forward|||||2,967|0|2,987| |as at 1 April 2019||||||||| |Total Funds carried forward||Note|3,172|247|8,419|2,397|108|2,505| |||16||||||| ## ||||2020I21|||2019I2020|| |---|---|---|---|---|---|---|---| |||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total| |||Funds|Funds|Funds|Funds|Funds|Funds| |||ir000|E'000|E'000|E'000|E'000|E'000| |Investments|Note 13||||2413|0|2413| |Total Fixed Assets||2,973|0|2,973|2,413|0|2,413| |Receivables|Note 14|15|0|15|21|0|21| |Stock||1|0|1|1|0|1| |Cash at bank and in hand||463|247|710|202|188|3$0| |Total Current Assets||47$|24'r|726|224|188|412| |Payables: falling due within|Note 15|(280)|0|(280)|(240)|0|(240)| |one year|||||||| |Net Current Assets I||199|||(16)|188|172| |(Llab8ltles)|||||||| |Total net assets||3172|247|3419|2397|188|2585| |Funds ofthe charity:|||||||| |Restricted|Note 16||247|247|0|186|188| |Unrestricted
Total Charity Funds|Note 16|3,172
3172|250|3,172
2,3$7
3192397||0
188|2,3$7
2 85| ## |Statement ofCash F|low|s|for the|year|ending 31|March 2021||| |---|---|---|---|---|---|---|---|---| ||||||||20/20/21|2019/20| ||||||||8'000|8'000| |Cash flows from operating
activities:||||||||| |Net cash provided
by (used in) operating||activities|||||293|(496)| |Cash flows from investing
activities:||||||||| |Dividends,
interest and rents from investments|||||||27|42| |Proceeds from sale ofinvestments|||||||0|0| |Purchase ofinvestments|||||||0|0| |Net cash provided
by (used in) investing|activities||||||27|42| |Change
in cash and cash equivalents|in the reporting|||period|||320|454| |Cash and cash equivalents
at the beginning|||ofthe reporting||period||390|844| |Cash and cash equivalents
at the end|ofthe reporting|||period|||710|390| |Reconciliation
ofnet Income/(expenditure)|||to net cash flow||from operating|activities||| |Net income/(expenditure)
forthe reporting|||period (as|per the|statement of|||| |financial activities)|||||||834|(402)| |Adjustments
for:||||||||| |(Gains)/losses
on investments|||||||(562)|128| |Dividends,
interest and rents from investments
(Increase)/dscrease
in stock|||||||(25)
0|(74)
0| |(Increase)/decrease
in receivables
Increase/(decrease)
in payables|||||||6
40|(20)
(128)| |Net cash provided
by (used in) operating||activities|||||293|496| |Analysis ofcash and cash equivalents||||||||| |Cash at bank and in hand|||||||710|390| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |Note 3In|com|e from donation|s
and legacies|s
and legacies||| |---|---|---|---|---|---|---| ||||2020/2021|||2019/20| ||||Unrestricted|Restricted|Total|Total| ||||Funds|Funds|Funds|Funds| ||||6'000|6'000|2'000|6'000| |Voluntary|Income:|||||| |Donations|||226|176|402|378| |Legacies|||354|0|354|143| |Trading|Income||11|0|11|28| |Total Voluntary||Income:|591|176|767|549| ## ## ## |ote|5Gr|oss I|nves|tment|Income||||| |---|---|---|---|---|---|---|---|---|---| ||||||||2020/2021||2019/20| |||||||Unrestricted|Restricted|Total|Total| |||||||Funds|Funds|Funds|Funds| |||||||6'000|2'000|6'000|6'000| |Fixed|asset|equity|and|similar|investments|27|0|27|42| |||||||27|0|27|42| ## ## ## ||||||2020/2021||2019/20| |---|---|---|---|---|---|---|---| |||||Grant|||| |||||funded|Support|Total|Total| |||||activity|costs|Expenditure|Expenditure| |||||8'000|E'000|8'000|8'000| |Patients welfare and amenities||||1|0|1|13| |Staff welfare and amenities||||191|22|213|88| |Research|Expenditure|||1|0|1|0| |Donations|ofequipment|and services to the Trust||163|19|182|675| |Volunteers|and miscellaneous||expenses|0|0|0|9| |||||356|41|397|785| ## ||||2020/2021|2020/2021|||2019/20| |---|---|---|---|---|---|---|---| |||Paid to|Paid to|Grant|Support|Total|Total| |||Individuals|Institutions|funded|costs|Expenditur|Expenditure| |||||activit||e|| |||E'000|K'000|y
E'000|E'000|8'000|8'000| |Patients welfare and|||||||13| |amenities|||0|1|||| |Staff welfare and|||||||88| |amenities||171|20|191|22|213|| |Research|||||||| |Expenditure|||1|1|||| |Donations|of||||||675| |equipment|and||||||| |services to|the Trust||158|163|19|182|| |Volunteers|and other||||||| |expenses|||0|0|||| |||177|179|356|41|397|785| ||||2020/2021|||2019/20|| |---|---|---|---|---|---|---|---| |||||Total|||| |||Direct|Support|Expenditur|Direct|Support|Total| |||expenditure
8'000|costs
8'000|e
8'000|expenditure
K'000|costs
8'000|Expenditure
8'000| |Patients|||||||| |welfare and|||||||| |amenities|||||12||13| |Staff welfare|||||||| |and amenities||191|22|213|84||88| |Research|||||||| |Expenditure|||||||| |Donations of|||||||| |equipment|and||||||| |services to|the||||||| |Trust||163|19|182|642|33|875| |Volunteers|and||||||| |miscellaneous|||||||| |expenses||0|0||6|1|| |||358|41|397|748|39|785| |Support costs analysis|K'000| |---|---| |Staff recharge|38| |Audit fees|3| |Total Costs|41| ## ## ## ## |in Note|9above and total E38,000.A|n analysis
ofthese c| |---|---|---| |||6'000| |Charitable|Fund Accountant|34| |Cashiers||3| |Accounts|assistant|1| |Total Costs||38| ## ## |econciliation
ofmovements
in i|nvestments
in the y|ear:|| |---|---|---|---| |||2020/2021|2019/20| |||f'000|f'000| |Market value brought
forward||2,413|2,511| |Add: additions to investments
at cost
Less: disposals at carrying
value
Add net gain(loss) on revaluation/Other|movements|0
0
560|1,649
(1,611)
~133| |Market value as at 31st March||2,973|2,413| |ixed asset investments
by ty|pe:||| |---|---|---|---| |||2020/2021|2019/20| |||f'000|f'000| |Investments-|||| |Fixed Interest||0|0| |UK Equities||121|110| |Overseas Equities||1,009|757| |UK Bonds||182|167| |Property/
Alternatives||200|205| |Multi Asset fund||1,357|1 323| |Total listed investments||2,889|2,262| |Cash held as part ofthe investment|porffolio|104|151| |||2973|2,413| ## |Receiv|ables due in less t|han a year:||| |---|---|---|---|---| ||||2020/2021|2019/20| ||||f'000|f'000| |Accrued|income||15|21| ||||18|21| |There|are no receivables|due in over a year.||| |iabilities|d|ue in|less|tha|n a|year:||| |---|---|---|---|---|---|---|---|---| ||||||||2020/2021|2018/19| ||||||||f'000|f'000| |Accruals|for|grants|owed|to|NHS|bodies|276|240| ## ||||Balance|Income|Expenditure|Transfers|Gains and|Fund cerned| |---|---|---|---|---|---|---|---|---| ||||brought||||Losses|forward| ||||forward|||||| ||||6'000|6'000|6'000|6'000|6'000|6'000| |Molesley|Hospital|and|168||(4)||33|199| |Harrowlands||||||||| |NHS Charities Together|||0|174|(149)||0|25| ||||168|176|(153)||33|224| |Analysis ofunrestricted|Analysis ofunrestricted|and material|designated|designated|fund|movements||| |---|---|---|---|---|---|---|---|---| |||Balance|Income|Expenditure||Transfers|Gains and|Fund| |||brought|||||Losses|carried| |||forward||||||forward| |||6'000|||8'000|6'000|6'000|6'000| |EPSOM INVASIVE||560|||-14|0|111|662| |CARDIAC SERVICES||||||||| |BUTTERFLY CENTRE|EGH|184||||||219| |General||139|331||-32|-347|48|139| |ST.HELIER FUND FOR||85|2||-2|0|17|103| |BLOOD DISORDERS||||||||| |R6D FUND-RAISING||76|1||-3|37|19|129| |SOUTH WEST LONDON||0|70||-5|250|31|348| |ELECTNE||||||||| |ORTHO.CENTRE||||||||| |Others||1,373|224||-331|60|267|1,594| |||2,417|638||-393|0|529|3194| ## ##